BEAMSTART Logo

Peter Weijmarshausen

Peter Weijmarshausen's Photo

Co-founder of Humane Genomics 


Join Date

November 2022

Gender

Not Specified

Age

Not Specified

Email

Log In to Access

Facebook

Not Specified

Instagram

Not Specified


About Peter Weijmarshausen

Building a highly efficient platform to make artificial viruses as cancer therapeutics.
Serial entrepreneur. Founder and former CEO of Shapeways.
Have built and led software and product teams for 3 companies.
Love to code, grow plants, brew beer, cook Asian food, and more.
BSc Applied Physics.

Companies & Work

Humane Genomics

Humane Genomics

Humane Genomics has developed a platform to engineer cancer killing viruses. We have taken a first principles approach to design and make oncolytic viral therapies. Using a highly lytic RNA virus engineered with "2 factor authentication" (using selective infection and selective replication) they have an on-target to off-target kill ratio > 1000. We are working on our first indication, pediatric liver cancer (hepatoblastoma), with our partners at Texas Children's Hospital, who are world leading experts. We have in vivo (mouse) data showing safety and currently developing efficacy data and are showing 50% reduction in tumor volume.

Share This Profile

Featured Members from United States

Ayan Bandyopadhyay

Co-founder of Psychic

Colin Elsinga

Co-founder of Metriport

Bhavin Gupta

Co-founder of Fynn

John Clarke

Co-founder of Algofi

Alexandra Johnson

Co-founder of Rubber Ducky Labs

Kevin Fu

Co-founder of Repool

BEAMSTART brings you the latest news, databases, and jobs from all around the world on startups, technology, and business. Stay updated with industry news, plug-in to exciting community events, and discover incredible career opportunities with the world's most innovative companies.

© Copyright 2024 BEAMSTART. All Rights Reserved.